Structure and antibacterial activities of new cyclic peptide antibiotics, pargamicins B, C and D, from Amycolatopsis sp. ML1-hF4

J Antibiot (Tokyo). 2017 May;70(5):699-704. doi: 10.1038/ja.2017.34. Epub 2017 Mar 15.

Authors

Hideki Hashizume¹, Ryuichi Sawa¹, Kazuma Yamashita¹, Yoshio Nishimura¹, Masayuki Igarashi¹

Affiliation

¹ Laboratory of Microbiology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.

PMID: 28293037
DOI: 10.1038/ja.2017.34

No abstract available

MeSH terms

Actinomycetales / metabolism*
Anti-Bacterial Agents* / chemistry
Anti-Bacterial Agents* / isolation & purification
Anti-Bacterial Agents* / pharmacology
Methicillin-Resistant Staphylococcus aureus / drug effects
Microbial Sensitivity Tests
Peptides, Cyclic* / chemistry
Peptides, Cyclic* / isolation & purification
Peptides, Cyclic* / pharmacology
Structure-Activity Relationship
Vancomycin-Resistant Enterococci / drug effects

Substances

Anti-Bacterial Agents
Peptides, Cyclic
pargamicin C